Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Shanghai Haoyuan Chemexpress Co's quarterly Total Liabilities
increased
from Sep. 2025 (¥2,936.84 Mil) to Dec. 2025 (¥3,108.54 Mil) and
increased
from Dec. 2025 (¥3,108.54 Mil) to Mar. 2026 (¥3,241.58 Mil).
Shanghai Haoyuan Chemexpress Co's annual Total Liabilities
increased
from Dec. 2023 (¥1,665.93 Mil) to Dec. 2024 (¥2,600.69 Mil) and
increased
from Dec. 2024 (¥2,600.69 Mil) to Dec. 2025 (¥3,108.54 Mil).
Shanghai Haoyuan Chemexpress Co Total Liabilities Related Terms
Shanghai Haoyuan Chemexpress Co Total Liabilities Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai Haoyuan Chemexpress Co Total Liabilities Chart
Shanghai Haoyuan Chemexpress Co Total Liabilities Calculation
Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai Haoyuan Chemexpress Co (SHSE:688131) has a Total Liabilities of ¥3,242 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Shanghai Haoyuan Chemexpress Co and its competitors.
Is Shanghai Haoyuan Chemexpress Co's Total Liabilities too high?
Shanghai Haoyuan Chemexpress Co's current Total Liabilities is ¥3,242 Mil. Overall, Shanghai Haoyuan Chemexpress Co has a GF Score™ of 92/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Shanghai Haoyuan Chemexpress Co's Total Liabilities compare to ZTS and UTHR?
Shanghai Haoyuan Chemexpress Co's Total Liabilities of ¥3,242 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Drug Manufacturers company?
A good Total Liabilities depends on the Drug Manufacturers industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Shanghai Haoyuan Chemexpress Co and its competitors. Shanghai Haoyuan Chemexpress Co's current Total Liabilities is ¥3,242 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Haoyuan Chemexpress Co stock overvalued right now?
Based on GuruFocus' analysis, Shanghai Haoyuan Chemexpress Co (SHSE:688131) is currently considered Fairly Valued. The stock's GF Value™ is ¥65.93, compared to a current price of ¥69.95 — trading 6.1% above its estimated fair value. The current Total Liabilities is ¥3,242 Mil. Shanghai Haoyuan Chemexpress Co's overall GF Score™ is 92/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Shanghai Haoyuan Chemexpress Co (SHSE:688131), the current Total Liabilities is ¥3,242 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shanghai Haoyuan Chemexpress Co (SHSE:688131) Overvalued in 2026?
Based on GuruFocus' analysis, Shanghai Haoyuan Chemexpress Co stock appears to be overvalued.
The current stock price of ¥69.95 is trading 6.1% above its estimated GF Value™ of ¥65.93.
GuruFocus considers Shanghai Haoyuan Chemexpress Co to be Fairly Valued.
Key valuation signals for SHSE:688131:
Total Liabilities: ¥3,242 Mil
GF Value™: ¥65.93 vs. price of ¥69.95 (6.1% above fair value)
No single metric tells the full story. See the SHSE:688131 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shanghai Haoyuan Chemexpress Co Business Description
Shanghai Haoyuan Chemexpress Co Ltd focuses on providing small molecule and new modalities CDMO services for both pharmaceutical and biotech clients. The company's comprehensive CRO & CDMO platform is engaged in the research and development, manufacturing and supply of regulatory starting materials, novel building blocks, intermediates, reference compounds, APIs and drug products. It is a one-stop service platform to support client's projects from early drug discovery, process development to commercialization. The company is committed to delivering high-quality products and CMC services to clients across the entire life cycle of drug development.
92GF Score
Get the complete analysis for SHSE:688131
Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688131 has been successfully added to your 
